| Bioactivity | RIPK-IN-4 is a potent and selective RIPK2 inhibitor with excellent oral bioavailability, and has an IC50 of 3 nM[1]. | ||||||||||||
| Target | IC50: 3 nM (RIPK2) | ||||||||||||
| Name | RIPK-IN-4 | ||||||||||||
| CAS | 2141969-56-2 | ||||||||||||
| Formula | C18H21FN4O3S | ||||||||||||
| Molar Mass | 392.45 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. He X, et al. Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases. ACS Med Chem Lett. 2017 Sep 27;8(10):1048-1053. |